Related Experiment Video
Updated: Jan 22, 2026
04:05
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.8K
Non-transplant Options in Advanced Heart Failure: Emergent Need for Guidelines ?
Srilakshmi M Adhyapak1, V Rao Parachuri2
1Associate Professor, Dept. of Cardiology, St. John's Medical College Hospital, Bangalore, Karnataka.
The Journal of the Association of Physicians of India
|July 16, 2019
Summary
Surgical revascularization improves survival in Coronary Artery Disease but poses challenges for patients with heart failure and co-morbidities. Rethinking high-risk surgical approaches is crucial when transplant options are limited.
Area of Science:
- Cardiovascular Surgery
- Heart Failure Management
Background:
- Coronary Artery Disease (CAD) survival has improved due to revascularization advances.
- Progressive heart failure remains a significant complication in CAD patients.
- Surgical revascularization in patients with left ventricular dysfunction presents unique challenges.
Purpose of the Study:
- To evaluate the feasibility and outcomes of high-risk surgical revascularization in patients with advanced Coronary Artery Disease and left ventricular dysfunction.
- To explore strategies for optimizing surgical revascularization in complex cardiac patients.
Main Methods:
- Review of surgical techniques for revascularization in patients with compromised cardiac function.
- Analysis of challenges including short cross-clamp and cardiopulmonary bypass times.
- Consideration of co-morbidities such as renal dysfunction and pulmonary vascular obstructive disease.
Main Results:
- Surgical revascularization offers prolonged survival but is complicated by progressive heart failure.
- Left ventricular dysfunction necessitates shorter surgical times, posing technical difficulties.
- Co-morbidities significantly increase surgical risks and deter success.
Conclusions:
- High-risk surgical revascularization requires careful consideration in patients with limited transplant options.
- Radical re-thinking of surgical strategies is needed for complex Coronary Artery Disease patients with heart failure.
- Optimizing surgical outcomes depends on managing co-morbidities and minimizing procedural times.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227